Inactive

The Defense Health Agency (DHA) Southeast Contracting Division intends to negotiate a contract on a sole source basis (IAW FAR 13.501(a) sole source acquisitions). The proposed source is Hologic Sales... The Defense Health Agency (DHA) Southeast Contracting Division intends to negotiate a contract on a sole source basis (IAW FAR 13.501(a) sole source acquisitions). The proposed source is Hologic Sales and Service, LLC; Cage Code: 5JP89 located at 250 Campus Drive Marlborough, MA 01752. The period of performance for the base year will be 16 January 2023 through 30 September 2023, with four options periods, if all options are exercised. The requirement is supplies for COVID testing to operate specifically on the Hologic Panther Analyzer. The item numbers consist of PRD-06419, Aptima SARS-CoV-2 Assay (40 Kits), PRD-06420 Aptima SARS CoV2 Controls (50 Kits), PRD-04339, Fusion Specimen Lysis Tubes (35 Tubes), PRD-06997 Hologic Direct Load Tubes (35 Tubes), PRD-03836 Universal Panel A ( 5 Panels), PRD-06506 Aptima SARS-CoV-2 Panel C (5 Panels), MME-04128 1000-ul Disposable Tips (10 Tips) and item number 301041 Aptima Unisex Swab Coll kit (10 kits), which are required for COVID-19 real-time testing on the existing Hologic Panther analyzer. Hologic is identified as the only company to provide COVID test supplies that are required for utilization on the Panther Analyzer. The Assay test reagents, Direct Load Tubes and Control kits are required to perform patient testing on the Hologic Panther analyzer. The Aptima assays have been validated for use with the Panther system. The firmware in the Panther system is necessary for running the Aptima assays and is unique to Hologic. The kits and reagents were developed and qualified to be used with the Aptima assays and may include proprietary technology. There are no set-aside restrictions for this requirement. The intended procurement will be classified under North America Industry Classification System (NAICS) 325413-In-Vitro Diagnostic Substance Manufacturing. This notice of intent is not a request for competitive proposals and no solicitation document exists for this requirement. However, parties interested in responding to this notice will need to submit technical data sufficient to determine capability in providing the same product. All capability statements received by the closing date of this synopsis will be considered by the Government. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. If a vendor challenges the basis of this requirement, please email product capability statements (formats for submission: PDF, MS Word, or MS Excel) to Annette Jackson at annette.d.jackson2.civ@health.mil and Jessica Horst at jessica.l.horst5.civ@health.mil. Closing date for challenges is no later than 03:00 PM ET on 27 December 2022. No phone calls will be accepted.